Mr Teti has twenty-five years experience in the pharmaceutical industry and ten years in the aesthetics space, most notably as the president and CEO of Inamed Corporation.

Mr Teti has served on the board of directors of Suneva since April 2009 and as chairman since July 2010. He was previously CEO of Isolagen, a biotechnology company which develops emergent, novel skin and tissue rejuvenation technologies.

From 2001 to 2006, Mr Teti was president and CEO of Inamed Corporation, a healthcare products manufacturer focused on marketing breast implants, dermal fillers to correct facial wrinkles, and devices to treat severe and morbid obesity, including the LAP-BAND Adjustable Gastric Banding System.

Mr Teti served on the board of Inamed in 2001 and was chairman of the board from 2002 to 2006 through the Allergan acquisition.

Prior to Inamed, Mr Teti spent 25 years at DuPont and DuPont Merck where he held a number of senior management positions including President and CEO of DuPont Pharmaceuticals. He currently serves on the board of enteromedics.

Todd Davis, vice chairman of Suneva, said: “Mr Teti has decades of industry experience and a proven leadership track record of growing companies. His expertise is critical to take Suneva to the next level of corporate growth and we are excited to have him join the senior management team.”

"We thank Mr Caviar for his commitment to re-launch Artefill into the US marketplace. This has given us a platform to accelerate the company forward."

Will Mr Teti’s leadership benefit the company?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.